Money hunt
7 hours ago
It’s ready FOXO Technologies to Unveil VITHAR™ AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time
November 08, 2023 09:00 AM Eastern Standard Time
MINNEAPOLIS--(BUSINESS WIRE)--FOXO Technologies Inc. (NYSE American: FOXO) (“FOXO” or the “Company”), a leader in the field of epigenetic biomarker technology, today announced that it will host a webinar on Friday, November 10, 2023, at 10 AM Eastern Time, which will be available on the Company’s website at https://foxotechnologies.com/.
The Company plans to unveil its new direct-to-consumer (DTC) app, the VITHAR™ AI Health Coach, which is designed to intake health data from available APIs already on the user's mobile and wearable devices, and combine this data with the individual’s epigenetic data through the Company’s proprietary epigenetic data and algorithms. The new DTC offering will leverage KR8’s AI ecosystem to provide users with actionable health insights and coaching.
Mark White, Interim CEO of FOXO Technologies, stated, “The FOXO and KR8 teams have been working tirelessly to develop the new VITHAR™ AI Health Coach. Current apps on the market provide basic DNA profiling and potential risk factors. However, by leveraging the power of FOXO’s patented epigenetic algorithms and data, we look forward to launching this new consumer-facing app, to provide unprecedented insight and easy-to-follow, personalized advice, based on epigenetic data to improve the user’s overall health and longevity. We look forward to unveiling the full offering in our upcoming webinar.”
About FOXO Technologies Inc. (“FOXO”)
FOXO, a technology platform company, is a leader in epigenetic biomarker discovery and commercialization focused on commercializing longevity science through products and services that serve multiple industries. FOXO's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. For more information about FOXO, visit www.foxotechnologies.com. For investor information and updates, visit https://foxotechnologies.com/investors/.
moe_the_gyp01
6 days ago
Hey MJAM2020, f$ck you laughing about, broke stuck? More Cumulative Convertible Redeemable Preferred Stock. Do you need a lesson on dilution? Surely, you are at the top of the class in dilution studies with your dead position in RNVA, no?
To approve, for purposes of complying with NYSE American Rule 713, pursuant to the terms of the Company’s Series A Cumulative Convertible Redeemable Preferred Stock (the “Series A Preferred Stock”): (i) the issuance of shares of Class A Common Stock in an amount equal to or in excess of 20% of our Class A Common Stock outstanding when the Series A Preferred Stock was authorized, upon conversion of the shares of Series A Preferred Stock; and (ii) the voting terms thereof, which may constitute a “Change of Control” as defined by the NYSE American Rules;